Smith & Nephew: poised to deliver share price recovery
The UK’s largest medical equipment company appears to offer an appealing risk/reward ratio for investors after a challenging 2020.
Covid-19 has had a profound effect on the performance of medical device company Smith & Nephew (LON:SN). Pandemic-related restrictions have prompted a fall in elective surgeries in key markets including the US and Europe, which has had a very negative impact on its financial performance. With lockdown measures remaining in place in many major economies and many of the company’s key markets, there is likely to be further disruption to the company’s operations in the short term. However, as the rollout of Covid-19 vaccines accelerates and containment measures are removed, we can expect to see a significant improvement in the…